Health

Herceptin linked to heart problems

NEWS IN BRIEF — Posted Sept. 19, 2005

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Food and Drug Administration notified physicians and others on Aug. 31 that analysis from data in a randomized phase III trial of the breast cancer drug Herceptin, or trastuzumab, uncovered a significant increase in heart problems among women who took the drug, compared with those who received chemotherapy alone.

A warning letter from the drug's maker, Genentech, posted on the FDA Web site, was sent to help with the early identification of cardiac toxicity, according to the company.

Preliminary analysis of safety data from the study revealed a statistically significant increase in the three-year cumulative incident of cardiotoxicity among the 1,019 women who took Herceptin, about 4%, compared with 0.8% among a similar number of controls.

Although there were no cardiac deaths among women taking Herceptin, there was one such death among the controls. The company said further analysis is ongoing.

Earlier results from randomized clinical trials showed that patients with early-stage HER-2 positive invasive breast cancer who received Herceptin in combination with chemotherapy had a significant decrease in risk for recurrence of their diseases, compared with patients who received only chemotherapy.

Approximately 20% to 30% of breast cancers produce too much of the HER-2 protein. These tumors tend to grow faster and are generally more likely to recur than are tumors that do not overexpress HER-2.

Note: This item originally appeared at http://www.ama-assn.org/amednews/2005/09/19/hlbf0919.htm.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn